Novartis Contracts

Sample Business Contracts from Novartis

Ancillary Development & Licensing Agreement - Novartis Pharma AG and Tanox Inc. (Feb 25, 2004)
Asset Purchase Agreement - Retrophin Inc. and Turing Pharmaceuticals AG (Feb 12, 2015)
Collaboration Agreement - Novartis Agribusiness Biotechnology Research Inc. and Diversa Corp. (Jan 25, 1999)
Collaboration Agreement - Rigel Pharmaceuticals Inc. and Novartis Pharma AG (May 26, 1999)
Collaboration Agreement [Amendment No. 1] - Rigel Pharmaceuticals Inc. and Novartis Pharma AG (May 18, 2001)
Collaboration Agreement [Amendment No. 2] - Rigel Pharmaceuticals Inc. and Novartis Pharma AG (Jul 6, 2001)
Collaborative Research and License Agreement [Amendment No. 1] - Cubist Pharmaceuticals Inc. and Novartis Pharma AG (Feb 4, 2002)
Collaborative Research and License Agreement - Cubist Pharmaceuticals Inc. and Novartis Pharma AG (Feb 3, 1999)
Collaborative Research and License Agreement - Novartis Pharma AG and Celgene Corp. (Dec 20, 2000)
Development and License Agreement - Celgene Corp. and Novartis Pharma AG (Apr 19, 2000)
Development and Licensing Agreement - Tanox Inc. and Novartis Pharma AG (Feb 25, 2004)
Joint Venture Agreement - Diversa Corp. and Novartis Seeds AG (Dec 1, 1999)
License Agreement - KaloBios Pharmaceuticals Inc. and Novartis International Pharmaceutical Ltd. (Mar 16, 2007)
Research and Development Agreement - Novartis Enzymes Inc. and Diversa Corp. (Dec 1, 1999)
Stock Purchase Agreement - Diversa Corp. and Novartis Agribusiness Biotechnology Research Inc. (Jan 25, 1999)
Stock Purchase Agreement - Novartis Pharma AG and Cubist Pharmaceuticals Inc. (Feb 1999)
Tripartite Cooperation Agreement - Novartis Pharma AG, Genentech Inc. and Tanox Inc. (Feb 25, 2004)